GeneCapture

Huntsville, AL · Founded 2009 · Privately Held (backing)

Developer of a medical diagnostic device designed to detect and identify pathogens and to bring infection detection to the point of care. GeneCapture is based in Huntsville, AL and was founded in 2009. Its last reported valuation was $23.5 million in Sep 2021. It has raised $7.4 million across 2 recorded rounds; the latest was a $500,000 seed round in Nov 2024.

Last reported valuation
$23.5M
Oct 2026
Priced at
—
Total raised
$7.4M
Last round
Seed Round
Nov 2024
What is GeneCapture worth?
$23.5Mlast reported valuation · Oct 2026

GeneCapture's last reported valuation, Sep 2021. Nothing priced has surfaced since.

Free account
More of GeneCapture with a free account
  • ·The complete investor list: 11 names
  • ·Watch GeneCapture: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

GeneCapture funding history

2 rounds
DateRoundRaisedPost-money
Nov 2024Seed Round$500K▮
Sep 2021Seed Round$1.2M▮
Unlock post-money valuations

Membership and data by Private Market View

GeneCapture valuation

GeneCapture's last reported valuation was $23.5 million in Sep 2021. No priced round, secondary trade or fund mark has surfaced since.

How much has GeneCapture raised?

GeneCapture has raised $7.4 million in total; 2 of its rounds are on record. The largest on record was a $500,000 seed round in Nov 2024.

GeneCapture has filed 10 Form Ds with the SEC since 2012, most recently in Dec 2024 ($500,000 sold to 1 investor).

How GeneCapture's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For GeneCapture, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about GeneCapture

What is GeneCapture worth?
GeneCapture is valued at $23.5M as of Oct 2026. GeneCapture's last reported valuation, Sep 2021. Nothing priced has surfaced since.
How much has GeneCapture raised?
GeneCapture has raised $7.4M in total funding across 2 recorded rounds.
When did GeneCapture last raise?
GeneCapture last raised in Nov 2024 (Seed Round), raising $500K.